LeaderStat

Future of Healthcare, Digital Healthcare

Veradigm | February 10, 2023

On February 9, 2023, Veradigm® Inc. announced that Veradigm® FollowMyHealth (previously FollowMyHealth), a top mobile-first patient engagement platform, was recently named Most Improved Software Product by KLAS, a leading healthcare solution evaluator in its 2023 Best in KLAS report. With a mobile-first strategy, Veradigm® FollowMyHealth helps meet patients on their terms and provides patient accessibility through an integrated patient engagement approach. A comprehe...

Health Technology

ZetrOZ Systems | May 30, 2022

ZetrOZ Systems, leaders in wearable medical technology and makers of the sam® wearable ultrasound device that heals soft tissue, highlighted the rising health insurance claim denials. The organization is encouraging customers to inform themselves about their healthcare policies and challenge the first denial. Millions of people in the U.S. have experienced the devastating denial of their healthcare claims. According to Change Healthcare, 11% of 102 million medical claims at 1,50...

Health Technology

Performant Capital | August 01, 2022

Performant Capital announced that it has formed Provider Technology, LLC through the acquisitions of DavLong Business Solutions LLC and its affiliate Administrative Advantage LLC and On Demand Solutions Inc. Provider Technology is a leading technology provider of outsourced software and IT services, revenue cycle management (“RCM”) and back-office business support primarily to physician practices and health systems. The businesses will continue to operate independently under their...

Health Technology

Antengene Corporation Limited | September 19, 2022

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...